GlaxoSmithKline Consumer Healthcare Ltd. - Research Center
500676 GSKCONS Group (A) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 19 |
Sep ' 18 |
Sep ' 17 |
Sep ' 16 |
Sep ' 15 |
Sales |
2,539.41 |
2,379.13 |
2,100.66 |
2,024.17 |
2,087.28 |
Operating profit |
676.21 |
583.96 |
427.71 |
448.69 |
442.88 |
Interest |
3.48 |
0.37 |
1.09 |
1.28 |
1.35 |
Gross profit |
877.44 |
769.05 |
537.28 |
564.41 |
555.35 |
EPS (Rs) |
141.08 |
113.16 |
77.18 |
81.87 |
89.48 |
Half yearly
results in details
|
Sep ' 19 |
Sep ' 18 |
Sep ' 17 |
Sep ' 16 |
Sep ' 15 |
Other income |
204.71 |
185.46 |
110.66 |
117.00 |
113.82 |
Stock adjustment |
18.25 |
9.54 |
42.05 |
-15.54 |
50.50 |
Raw material |
674.26 |
659.18 |
622.35 |
593.41 |
575.33 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
343.55 |
323.07 |
263.46 |
247.75 |
241.00 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
282.35 |
276.49 |
264.94 |
248.74 |
263.88 |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
544.79 |
526.89 |
480.15 |
501.12 |
513.69 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
39.95 |
29.77 |
34.69 |
29.42 |
32.87 |
Taxation |
244.10 |
263.35 |
177.96 |
190.66 |
202.16 |
Net profit / loss |
593.39 |
475.93 |
324.63 |
344.33 |
376.37 |
Extra ordinary item |
- |
- |
- |
- |
56.05 |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
42.06 |
42.06 |
42.06 |
42.06 |
42.06 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
26.63 |
24.55 |
20.36 |
22.17 |
21.22 |
GPM (%) |
31.98 |
29.99 |
24.30 |
26.36 |
25.23 |
NPM (%) |
21.62 |
18.56 |
14.68 |
16.08 |
17.10 |